This is an old revision of this page, as edited by Kafziel (talk | contribs) at 19:41, 12 February 2012 (Zubrin does not redirect here; rm unnecessary hatnote). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 19:41, 12 February 2012 by Kafziel (talk | contribs) (Zubrin does not redirect here; rm unnecessary hatnote)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATCvet code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
IUPAC name
| |
| PubChem CID | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.166.553  |
| Chemical and physical data | |
| Formula | C20H20ClN3O3 |
| Molar mass | 385.844 g/mol g·mol |
| (verify) | |
Tepoxalin is a nonsteroidal anti-inflammatory drug approved for veterinary use (in dogs) in the United States and the European Union. It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as hip dysplasia and arthritis.
It is generally marketed under the brand name Zubrin.
References
 | This veterinary medicine–related article is a stub. You can help Misplaced Pages by expanding it. |